42.31
전일 마감가:
$42.59
열려 있는:
$42.73
하루 거래량:
365.37K
Relative Volume:
0.84
시가총액:
$1.16B
수익:
$86.93M
순이익/손실:
$-1.48M
주가수익비율:
-596.76
EPS:
-0.0709
순현금흐름:
$431.00K
1주 성능:
+3.02%
1개월 성능:
+18.52%
6개월 성능:
+181.32%
1년 성능:
+174.74%
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
명칭
Eton Pharmaceuticals Inc
전화
(847) 787-7361
주소
21925 W. FIELD PARKWAY, DEER PARK, IL
Compare ETON vs TAK, HLN, TEVA, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
ETON
Eton Pharmaceuticals Inc
|
42.31 | 1.17B | 86.93M | -1.48M | 431.00K | -0.0709 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.44 | 55.06B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
HLN
Haleon Plc Adr
|
9.94 | 43.07B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.08 | 35.88B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
ZTS
Zoetis Inc
|
76.92 | 31.59B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
UTHR
United Therapeutics Corp
|
527.94 | 26.32B | 3.17B | 1.29B | 1.01B | 27.09 |
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-23 | 재확인 | H.C. Wainwright | Buy |
| 2025-01-10 | 개시 | B. Riley Securities | Buy |
| 2025-01-06 | 재확인 | H.C. Wainwright | Buy |
| 2024-09-04 | 재개 | H.C. Wainwright | Buy |
| 2024-05-06 | 개시 | Craig Hallum | Buy |
| 2021-10-14 | 재개 | B. Riley Securities | Buy |
| 2021-01-04 | 재확인 | H.C. Wainwright | Buy |
| 2019-09-20 | 개시 | B. Riley FBR | Buy |
| 2019-06-10 | 개시 | H.C. Wainwright | Buy |
모두보기
Eton Pharmaceuticals Inc 주식(ETON)의 최신 뉴스
Eton Pharmaceuticals Inc (ETON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
ETON|Eton Pharmaceuticals Inc|Price:42.590|Chg%:-1.550 - TradingKey
The Technical Signals Behind (ETON) That Institutions Follow - Stock Traders Daily
Eton Pharmaceuticals (ETON) Short Interest & Short Float | Updated Jul 2026 - MarketBeat
Eton Pharmaceuticals stock hits all-time high at 44.0 USD - Investing.com UK
Eton Pharmaceuticals stock hits all-time high at 44.0 USD By Investing.com - Investing.com Nigeria
Eton Pharmaceuticals Inc. (ETON) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Eton Pharmaceuticals: Here Is How I Handle My Position With The Stock Skyrocketing (Downgrade) - Seeking Alpha
Eton Pharmaceuticals (ETON) moves 13.8% higher: Will this strength last? - MSN
Eton Pharmaceuticals (ETON) Gains On Rare Disease Momentum, Is It Still Undervalued? - Sahm
Eton Pharmaceuticals Inc (ETON) Shares Fall 3.1% -- What GF Scor - GuruFocus
Eton Pharmaceuticals (ETON) Moves 13.8% Higher: Will This Strength Last? - Yahoo Finance
Eton Pharmaceuticals (ETON) Surges 13.8%: Breaking Above Key Resistance LevelsQuality ETF - dars.gov.et
ETON Surges As Canaccord Sets Aggressive $60 Price Target - StocksToTrade
ETON Jumps As Canaccord’s $60 Price Target Signals Growth - timothysykes.com
Opaleye management sells $1.06m in Eton Pharmaceuticals stock By Investing.com - Investing.com Australia
Form 4 Eton Pharmaceuticals Inc For: 17 July By Investing.com - Investing.com India
Opaleye management sells $1.06m in Eton Pharmaceuticals stock - Investing.com
Opaleye Management sells 28315 Eton Pharmaceuticals (ETON) shares on July 14 - Stock Titan
ETON Stock Pops As Canaccord Genuity Targets $60 - timothysykes.com
ETON PHARMACEUTICALS INC : CANACCORD GENUITY INITIATES COVERAGE WITH BUY RATING; TARGET PRICE $60 - Bitget
Form 4 Eton Pharmaceuticals Inc For: 16 July By Investing.com - Investing.com Nigeria
Eton Pharmaceuticals stock hits all-time high at 38.76 USD By Investing.com - Investing.com South Africa
Eton Pharmaceuticals stock hits all-time high at 38.76 USD - Investing.com UK
Opaleye management sells $1.06m Eton Pharmaceuticals stock By Investing.com - Investing.com Canada
Opaleye management sells $1.06m Eton Pharmaceuticals stock - Investing.com
Eton Pharmaceuticals (ETON) holder Opaleye reports July stock sales - Stock Titan
Form 4 Eton Pharmaceuticals Inc For: 14 July By Investing.com - Investing.com Canada
Eton Pharmaceuticals (ETON) CEO exercises options and RSUs, increasing stake - Stock Titan
Eton Pharmaceuticals (NASDAQ: ETON) CBO converts 10,000 RSUs into common shares - Stock Titan
Eton Pharmaceuticals (ETON) Edges Higher as Stock Tests Key Resistance LevelsDark Pool Volume - dars.gov.et
Major Investor Makes Bold Move in Eton Pharmaceuticals - TipRanks
Opaleye management sells $4.77m Eton Pharmaceuticals (ETON) stock By Investing.com - Investing.com Nigeria
Form 4 Eton Pharmaceuticals Inc For: 7 July By Investing.com - Investing.com Nigeria
Opaleye management sells $4.77m Eton Pharmaceuticals (ETON) stock - Investing.com
Form 4 Eton Pharmaceuticals Inc For: 7 July - Investing.com India
Opaleye trims Eton Pharmaceuticals (ETON) stake with open-market sales - Stock Titan
Eton Pharmaceuticals highlights its niche rare-disease focus as a specialty drug developer - Ad-hoc-news.de
Eton Pharmaceuticals stock hits all-time high at 38.6 USD By Investing.com - Investing.com Nigeria
Eton Pharmaceuticals stock hits all-time high at 38.6 USD - Investing.com
Frontier tech research, news & data - MLQ.ai
Precision Trading with Eton Pharmaceuticals Inc. (ETON) Risk Zones - Stock Traders Daily
Enterprise value to revenue forward of Eton Pharmaceuticals, Inc. – NASDAQ:ETON - TradingView
Form 4 Eton Pharmaceuticals Inc For: 30 June By Investing.com - Investing.com Nigeria
Eton Pharmaceuticals (ETON) CBO awarded 10,000 restricted stock units - Stock Titan
Eton Pharmaceuticals stock hits all-time high at 36.97 USD - Investing.com
Eton Pharmaceuticals stock hits all-time high at 36.97 USD By Investing.com - Investing.com Nigeria
Eton Pharmaceuticals Inc (ETON) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):